SGLT-2 Inhibition and Ocular Outcomes in T2DM
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Sodium-Glucose Co-Transporter-2 Inhibition and Ocular Outcomes in Patients With Type 2 Diabetes: A Systematic Review and Meta-Analysis
Diabetes Obes Metab 2020 Sep 21;[EPub Ahead of Print], C Li, Z Zhou, BL Neuen, J Yu, Y Huang, T Young, J Li, L Li, V Perkovic, MJ Jardine, L Keay, M Markoulli, N Rosenthal, G Capuano, Y Yavin, B Neal, C ArnottFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.